Gilead Sciences · 2 months ago
Postdoctoral Scientist (HIV CURE)
Gilead Sciences is dedicated to tackling major health challenges and is seeking a highly motivated Postdoctoral Scientist to join their Virology group. The role involves investigating HIV cure research, focusing on understanding proviral activity and persistence through advanced molecular and cellular assays, while collaborating with various teams and contributing to scientific publications.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Conducts scientific research to advance understanding of HIV latency and reservoir dynamics
Applies principles and techniques of molecular virology and immunology to investigate latency reversal mechanisms
Works under supervision of senior scientists to develop and optimize assays for proviral quantification, transcriptional profiling, and integration site mapping
Designs and implements experiments using primary CD4+ T cells from ART-suppressed individuals to evaluate transcriptional responses to relevant stimuli
Collaborates with internal and external teams to integrate sequencing, flow cytometry, and single-cell transcriptomics
May advise research associates or project team members in the initiation and execution of laboratory experiments
Qualification
Required
PhD in molecular virology, immunology, cell biology, or a related scientific discipline is required
Ability to develop methods, techniques, and evaluation criteria for obtaining results
Technical proficiency, scientific creativity, collaboration with others, and independent thought in suggesting experimental design and research strategy
Strong verbal communication and interpersonal skills
Must be able to participate in highly effective teams
Preferred
Experience with HIV molecular assays (e.g., IPDA, CA-RNA, near full-length sequencing) and primary cell culture preferred
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2026-01-16
FierceBiotech
2026-01-16
Company data provided by crunchbase